Poster Presentation at ASCO 2023

Presentation details:

Abstract Title:	Uliledlimab and Toripalimab Combination Therapy in Treatment Naïve Advanced NSCLC: Phase 1b/2 Clinical Trial Results Using CD73 as a Potential Predictive Biomarker
Abstract Number:	2570
Presenting Author:	Prof. Qing Zhou, Guangdong Provincial People’s Hospital
Session:	Developmental Therapeutics – Immunotherapy
Location:	Hall A, McCormick Place Convention Center, Chicago, Illinois
Presentation Date/Time:	June 3, 2023, 8:00 am – 11:00 am C.T.